When RNA gets hijacked, an aggressive form of kidney cancer grows—and scientists at Texas A&M Health have finally learned how to make it stop.

Translocation renal cell carcinoma (tRCC) is driven by MiT family gene fusions. Here, the authors demonstrate that RNA-binding features of TFE3 fusions facilitate condensate formation, promoting transcriptional hub assembly and oncogenic gene activation.

Salicylic acid, a commonly used skincare and pain medication ingredient, could now also be used to treat blood cancers.

A highly compact chemically induced proximity system dependent on salicylic acid or aspirin enables control of biological processes and cellular therapeutics using an over-the-counter drug with minima...

There remains a demand for optogenetic tools that provide modularity, ease of integration, and minimal interference with protein function. Here, authors introduce PhoBITs as compact and modular optoge...

Cancer immunotherapy has revolutionized oncology, but its full potential remains constrained by treatment resistance, limited durability, immune evasion, and systemic toxicity. Overcoming these obstac...

Join us at the Houston Cell & Gene Therapy Symposium 2025 at Levit Green (C4B) for cutting-edge talks, networking & innovation!